

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb60560</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>One-step and Rapid Identification of SARS-CoV-2 using Real-Time Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP)</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Shoushtari</surname><given-names>Mohammad</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Zeinoddini</surname><given-names>Mehdi</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Fathi</surname><given-names>Javad</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Keshavarz Alikhani</surname><given-names>Hani</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Shiekhi</surname><given-names>Fatemeh</given-names></name></contrib></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>16</volume>
      <issue>1</issue>
      <fpage>3</fpage>
      <lpage>8</lpage>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>5</month>
          <year>2023</year>
        </date>
        <date date-type="accepted">
          <day>29</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Background:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; SARS-CoV-2 as the cause of novel coronavirus disease (COVID-19) is a member of the family &lt;em&gt;Coronaviridea&lt;/em&gt; that has generated an emerging global health concern. Controlling and preventing the spread of the disease requires a simple, portable, and rapid diagnostic method. Today, a standard method for detecting SARS-CoV-2 is &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;quantitative real-time reverse transcription PCR, which is time-consuming and needs an advanced device. &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;The aim of this study was to evaluate a faster and more cost-effective field-based testing method at the point of risk. We utilized a one-step RT-LAMP assay and developed, for the first time, a simple and rapid screening detection assay targeting the Envelope (&lt;em&gt;E&lt;/em&gt;) gene, using specific primers. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Methods:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; For this,&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; the total &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;RNA was extracted from respiratory samples of COVID-19&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; infected &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;patients &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;and &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;applied to one-step a &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;RT-LAMP&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; reaction.&lt;/span&gt; &lt;span style=&quot;font-size:10.0pt&quot;&gt;The LAMP products were visualized using green fluorescence (SYBR Green I). Sensitivity testing was conducted using different concentrations of the designed recombinant plasmid (TA-E) as positive control constructs. Additionally, selectivity testing was performed using the influenza H1N1 genome. Finally, the results were compared using with conventional real time RT-PCR. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Results:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; It was shown that the RT-LAMP assay has a sensitivity of approximately 15 &lt;em&gt;ng&lt;/em&gt; for the &lt;em&gt;E&lt;/em&gt; gene of SARS-CoV-2 when using extracted total RNA. Additionally, a sensitivity of 112 &lt;em&gt;pg&lt;/em&gt; was achieved when using an artificially prepared TA-E plasmid. Accordingly, &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;for the detection of &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;SARS-CoV-2 &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;infection,&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; the &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;RT-LAMP had high sensitivity and specificity and also could be an alternative method for real-time RT-PCR.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;Conclusion:&lt;/span&gt;&lt;/strong&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; Overall, &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;this method can be used as a portable, rapid, and easy method for detecting &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;SARS-CoV-2 &lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt;in the field and clinical laboratories.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
